Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis
Molecular Therapy · 2023
DOI: 10.1016/j.ymthe.2023.06.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2023. Verfasst von Chao Li und 24 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Educ…. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Gastrin-releasing peptide (GRP) binds to its receptor (GRP receptor [GRPR]) to regulate multiple biological processes, but the function of GRP/GRPR axis in acute kidney injury (AKI) remains unknown. In the present study, GRPR is highly expressed by tubular epithelial cells (TECs) in patients or mice with AKI, while histone deacetylase 8 may lead to the transcriptional activation of GRPR. Functionally, we uncovered that GRPR was pathogenic in AKI, as genetic deletion of GRPR was able to protect mice from cisplatin- and ischemia-induced AKI. This was further confirmed by specifically deleting the GRPR gene from TECs in GRPRFlox/Flox//KspCre mice. Mechanistically, we uncovered that GRPR was able to interact with Toll-like receptor 4 to activate STAT1 that bound the promoter of MLKL and CCL2 to induce TEC necroptosis, necroinflammation, and macrophages recruitment. This was further confirmed by overexpressing STAT1 to restore renal injury in GRPRFlox/Flox/KspCre mice. Concurrently, STAT1 induced GRP synthesis to enforce the GRP/GRPR/STAT1 positive feedback loop. Importantly, targeting GRPR by lentivirus-packaged small hairpin RNA or by treatment with a novel GRPR antagonist RH-1402 was able to inhibit cisplatin-induced AKI. In conclusion, GRPR is pathogenic in AKI and mediates AKI via the STAT1-dependent mechanism. Thus, targeting GRPR may be a novel therapeutic strategy for AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui…
- Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Anhui Public Health Clinical Center, No. 100 Huaihai Road, Hefei 230012, China.
- Department of Nephrology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
- School of Food and Biological Engineering, Hefei University of Technology, Hefei 230009, China.
- Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei 230032, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China.
Zitieren
APA
Li, C., Ma, Q. Y., Liu, X. Q., Li, H. D., Yu, M. J., Xie, S. S., Ma, W. X., Chen, Y., Wang, J. N., He, R. B., Bian, H. G., He, Y., Gao, L., Deng, S. S., Zang, H. M., Gong, Q., Wen, J. G., Liu, M. M., Yang, C., …, & Meng, X. M. (2023). Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.06.016
Vancouver
Li C, Ma QY, Liu XQ, Li HD, Yu MJ, Xie SS, et al. Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis. Molecular Therapy. 2023. doi:10.1016/j.ymthe.2023.06.016
BibTeX
@article{Li2023,
author = {Li, Chao and Ma, Qiu-Ying and Liu, Xue-Qi and Li, Hai-di and Yu, Ming-Jun and Xie, Shuai-Shuai and Ma, Wen-Xian and Chen, Ying and Wang, Jia-Nan and He, Ruo-Bing and Bian, He-Ge and He, Yuan and Gao, Li and Deng, Sheng-Song and Zang, Hong-Mei and Gong, Qian and Wen, Jia-Gen and Liu, Ming-Ming and Yang, Chen and Chen, Hai-Yong and Li, Jun and Lan, Hui-Yao and Jin, Juan and Yao, Ri-Sheng and Meng, Xiao-Ming},
title = {Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis},
journal = {Molecular Therapy},
year = {2023},
doi = {10.1016/j.ymthe.2023.06.016}
}
EUVIMED